Researchers in Australia hope the genetic study will help take the guesswork out of prescribing medications for depression, the Hack says.
The international team of researchers also examined the genetic ties between personality traits and psychiatric disorders.
23andMe's database has enabled it to link loci to disease and fuel better understanding of diseases like depression, KQED Science says.
The company has recently launched its first diagnostic test on the market and is developing a second, which is currently in clinical trials.
In Nature this week: loci linked to major depressive disorder, and more.
With genotypes for hundreds of thousands of individuals, investigators uncovered 15 loci linked to major depressive disorder in individuals with European ancestry.
The firm plans to launch testing in the US this fall through Atlanta-based Alpha Genomix, and is looking for similar partners in Asia for a new Asia-specific panel.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
The company's test, CNSDose, incorporates multiple genes involved in metabolism of antidepressants in the liver and how they cross into the brain via the blood-brain-barrier.
A genome-wide association study of some 89,000 people linked variants in circadian rhythm genes to being a morning person.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.